IMM 1.45% 34.0¢ immutep limited

hypothtical sp, page-7

  1. 5,939 Posts.
    lightbulb Created with Sketch. 3
    DNDN gets a mention on CNBC at open.

    I remember reading six months ago a number of analylists were touting the Medicaid decision as being as significant as initial FDA approval.

    It looks like it's all good news.

    Great news for PRR's CVac. The Australian market will prob not pick up on this.

    The sooner we start trading on the NASDAQ the better.

    Everyone should have a little PRR in their portfolio. Potential massive gains here if...
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.